The COMBAT HBV Feasibility Trial

Clinical trial NCT05705427 · COMPLETED

Trial details

NCT number: NCT05705427
Sponsor: University of North Carolina, Chapel Hill
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis B Vertical Transmission of Infectious Disease

Start date: 2023-08-17
Primary completion: 2025-11-25
Enrollment: 317

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.